Skip to main content
. 2017 Oct 12;8(58):98405–98416. doi: 10.18632/oncotarget.21846

Figure 2. The inhibitory effect of deferasirox and DFO on miPS-LLCcm cells in vitro.

Figure 2

(A) Cultured miPS-LLCcm cells were treated with different concentrations of deferasirox and DFO for 48 hours and cell viability was then evaluated using the XTT assay. Cell viability in the absence of treatment was set at 100%. Results are means of 3 independent experiments. Data are represented as average ± S.E.M. (n = 5). ***p < 0.001. (B) Normal and fluorescence microscopy findings showed that numbers of GFP positive and negative cells were decreased in a dose dependent manner.